We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass., May 2, 2024 CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 305.3 | 305.3 | 305.3 | 21726 | 305.3 | DE |
4 | 0 | 0 | 305.3 | 305.3 | 305.3 | 12599 | 305.3 | DE |
12 | 0 | 0 | 305.3 | 305.3 | 305.3 | 46962 | 305.3 | DE |
26 | 0 | 0 | 305.3 | 305.3 | 305.3 | 57957 | 305.3 | DE |
52 | 0 | 0 | 305.3 | 305.3 | 305.3 | 72633 | 305.3 | DE |
156 | 0 | 0 | 305.3 | 305.3 | 305.3 | 50815 | 305.3 | DE |
260 | 0 | 0 | 305.3 | 305.3 | 305.3 | 39456 | 305.3 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions